Rocket Lab Corporation Common Stock
RKLB
$67.73
+3.37%
Rocket Lab is a space company operating in the Aerospace & Defense industry, providing end-to-end mission services and manufacturing launch vehicles and spacecraft. It is a key player in the small launch and space systems market, with a core advantage in offering frequent and reliable access to space.…
RKLB
Rocket Lab Corporation Common Stock
$67.73
Related headlines
Investment Opinion: Should I buy RKLB Today?
Based on a synthesis of the data, the objective assessment for RKLB is a Hold for most investors, with a speculative Buy rating only for those with a very high risk tolerance and long-term horizon. The company's strong growth trajectory and contract momentum are compelling, but they are fully—if not overly—reflected in the current sky-high valuation. The lack of profitability and high cash burn necessitate that any investment be framed as a bet on long-term execution, not current fundamentals. Therefore, it is not suitable for conservative portfolios.
Sign up to view all
RKLB 12-Month Price Forecast
The fundamental growth story is intact, but risk and reward are asymmetrically skewed due to valuation. The high probability base case suggests limited near-term upside from current levels without a significant expansion of already-rich multiples, while the bear case presents substantial downside risk.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Rocket Lab Corporation Common Stock's 12-month outlook, with a consensus price target around $88.05 and implied upside of +30.0% versus the current price.
Average Target
$88.05
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$54 - $88
Analyst target range
No sufficient analyst coverage available. The provided data includes recent institutional rating actions but does not contain a consensus target price or ratings distribution. Recent analyst actions from firms like Morgan Stanley (upgraded to Overweight), Needham (Buy), and Goldman Sachs (Neutral) indicate ongoing coverage, but specific quantitative targets are not provided in the input data.
Bulls vs Bears: RKLB Investment Factors
Rocket Lab presents a classic high-risk, high-reward growth story. Bullish drivers center on strong operational momentum, contract wins, and a solid financial position. However, these are counterbalanced by severe valuation concerns, persistent losses, and significant market volatility. The stock is a pure play on future space industry growth.
Bullish
- Strong Revenue Growth: Q4 2025 revenue grew 35.7% YoY, showing robust demand.
- Major Contract Wins: Recent $190M DOD contract boosts backlog and future revenue.
- Solid Balance Sheet: Low debt-to-equity of 0.15 and strong current ratio of 4.08.
- Strategic Acquisitions: Approved Mynaric deal expands capabilities in key laser tech.
Bearish
- Persistent Unprofitability: Negative net margin of -29.5% and significant cash burn.
- Extreme Valuation: Price-to-Sales ratio of 61.5 is exceptionally high.
- High Volatility: Beta of 2.207 indicates stock is over twice as volatile as market.
- Execution & Integration Risk: Success of growth and acquisitions hinges on flawless execution.
RKLB Technical Analysis
Overall Assessment: The stock has exhibited significant volatility over the observed six-month period, with a strong upward trend from October 2025 to a peak near $96 in January 2026, followed by a sharp correction. Despite the recent pullback, the stock remains up 22.39% over the last six months and a remarkable 259.17% over the past year, significantly outperforming the broader market.
Short-term Performance: Over the last month, the stock has declined by 7.06%, underperforming the S&P 500's 5.25% drop. The three-month performance is also negative, down 7.94%, which is a steeper decline than the S&P 500's 4.63% fall. This indicates recent weakness and negative short-term momentum.
Current Position: The current price of $64.22 is well above the 52-week low of $14.71 but significantly below the 52-week high of $99.58, placing it roughly in the middle of its annual range. The stock's beta of 2.207 confirms its high volatility relative to the market.
Beta
2.21
2.21x market volatility
Max Drawdown
-43.0%
Largest decline past year
52-Week Range
$15-$100
Price range past year
Annual Return
+250.2%
Cumulative gain past year
| Period | RKLB Return | S&P 500 |
|---|---|---|
| 1m | -3.4% | -3.6% |
| 3m | -10.9% | -4.0% |
| 6m | +20.6% | -2.0% |
| 1y | +250.2% | +16.2% |
| ytd | -10.9% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RKLB Fundamental Analysis
Revenue & Profitability: The company is showing strong revenue growth, with Q4 2025 revenue of $179.65 million representing a 35.7% year-over-year increase. However, profitability remains a major challenge, as the company continues to report significant net losses. The Q4 2025 net margin was -29.5%, though this is an improvement from the -39.5% net margin in Q4 2024.
Financial Health: The balance sheet appears solid with a strong current ratio of 4.08, indicating ample liquidity to cover short-term obligations. The debt-to-equity ratio is low at 0.147, suggesting a conservative capital structure with minimal reliance on debt financing. A key concern is the negative free cash flow of -$321.8 million over the trailing twelve months, indicating the company is still burning cash to fund operations and growth.
Operational Efficiency: The company's operational metrics reflect its growth stage. Return on Equity (ROE) is deeply negative at -11.5%, and Return on Assets (ROA) is -8.15%, indicating it is not yet generating positive returns on its invested capital. The gross margin for Q4 2025 was 37.98%, showing an ability to generate a reasonable profit on its core products and services before operating expenses.
Quarterly Revenue
$179652000.0B
2025-12
Revenue YoY Growth
+0.35%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$-321806000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RKLB Overvalued?
Valuation Level: Given the company's negative net income and EBITDA, traditional P/E and EV/EBITDA ratios are not meaningful. Therefore, the valuation is assessed using the Price-to-Sales (PS) ratio, which stands at 61.5, and the Enterprise Value-to-Sales (EV/Sales) ratio of 59.3. These metrics indicate a very high valuation relative to current revenue, typical for a high-growth, pre-profitability company in a capital-intensive industry.
Peer Comparison: Data not available for a direct industry average comparison. The extremely high sales multiples reflect investor expectations for massive future growth and market share capture in the commercial space sector, rather than current financial performance.
PE
-186.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -347x~434x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-234.4x
Enterprise Value Multiple
Investment Risk Disclosure
Rocket Lab carries a high-risk profile, characteristic of a pre-profitability company in a capital-intensive industry. The primary financial risk is the sustained negative free cash flow (-$321.8M TTM), indicating the company is still reliant on external funding to finance operations and ambitious growth plans like the Neutron rocket. While the balance sheet is currently strong, prolonged cash burn could pressure liquidity.
Market and execution risks are significant. The stock's beta of 2.207 confirms extreme sensitivity to broader market sentiment and risk appetite. Recent news highlights macro risks from Fed policy and Middle East tensions, which can disproportionately impact speculative growth stocks. Furthermore, the company faces intense execution risk in integrating acquisitions (Mynaric) and developing new launch vehicles, where delays or cost overruns could severely damage investor confidence.
Competitive and valuation risks are paramount. The impending SpaceX IPO is a double-edged sword; while it may boost sector interest, it also introduces a formidable, well-capitalized public competitor. The most glaring risk is the extreme valuation, with a PS ratio over 60. This prices in near-perfect execution and massive future market capture, leaving the stock vulnerable to sharp corrections if growth expectations are not met or if the market sours on high-multiple stories.
FAQ
The key risks include persistent unprofitability and cash burn (-$321.8M FCF TTM), extreme stock volatility (beta of 2.207), and high execution risk on new projects and acquisitions. Additionally, the lofty valuation makes the stock vulnerable to a sharp de-rating. Macro factors like interest rates and geopolitical tensions also disproportionately impact high-growth, speculative stocks like RKLB.
The 12-month outlook is highly volatile. The base case (50% probability) sees the stock trading between $55 and $85, as growth continues but high valuation caps major upside. A bull case (25%) could see a rally to $90-$110 on flawless execution and sector tailwinds. A bear case (25%) risks a drop to $30-$50 on missed targets or a market downturn.
Based on traditional metrics, RKLB appears significantly overvalued. With a negative P/E and a Price-to-Sales ratio of 61.5, the stock is priced for massive future growth that has yet to materialize. This valuation reflects high investor optimism for the space sector but also introduces substantial downside risk if growth expectations are not met.
RKLB is a speculative buy only for investors with a very high risk tolerance and long-term horizon. While the company shows strong revenue growth (35.7% YoY in Q4) and has won major contracts, it is not yet profitable and trades at an extremely high Price-to-Sales ratio of 61.5. This valuation leaves little margin for error, making it unsuitable for conservative portfolios.
RKLB is strictly suitable for long-term investment, if at all. The company is in a capital-intensive growth phase, and realizing its potential depends on multi-year projects like the Neutron rocket. The stock's high beta of 2.207 makes it extremely volatile and risky for short-term trading. Investors must be prepared to hold for 5+ years to see the underlying business mature.